Felodipineextended-release Tablets
Pricing Report NDC 63304-436-01

View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

The latest wholesale acquisition cost for Felodipineextended-release Tablets (NDC 63304-436-01) is $0.45924 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since May 20, 2015.

As a provided by Ranbaxy Pharmaceuticals Inc, this medication is distributed in a 100 TABLET, EXTENDED RELEASE in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$0.45924
Per EA

Effective Date
May 20, 2015
Billable Units
100 EA
Estimated Package Price
$45.92
Data Status
As of May 20, 2015
C/I - Chain or Independent Pharmacy
Package NDC
Description
100 TABLET, EXTENDED RELEASE in 1 BOTTLE
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Nov 2013, the NADAC wholesale price for (NDC ) has moved within a range of $0.42040 to $0.50056 per EA. Over this 1 year and 5 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.4204 - $0.5006
Market Volatility
19.07% Variance
Latest Trend
9.24%
Date Unit Price Unit Source Method Rate
May 20, 2015 $0.45924 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Apr 22, 2015 $0.42040 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Mar 18, 2015 $0.46979 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Feb 18, 2015 $0.49248 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jan 21, 2015 $0.46370 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Dec 17, 2014 $0.46299 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Nov 19, 2014 $0.47247 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Oct 22, 2014 $0.45709 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Sep 17, 2014 $0.48869 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Aug 20, 2014 $0.49381 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jul 23, 2014 $0.47335 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jun 18, 2014 $0.49358 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
May 21, 2014 $0.49686 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Apr 23, 2014 $0.48412 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Mar 19, 2014 $0.49489 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Feb 19, 2014 $0.50056 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jan 22, 2014 $0.47580 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Dec 18, 2013 $0.49489 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Nov 21, 2013 $0.45165 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: July 08, 2026